Oncolytic adenoviral vector carrying the cytosine deaminase gene for melanoma gene therapy
نویسندگان
چکیده
منابع مشابه
An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy.
Targeting gene expression to cancer cells remains a challenge for the development of gene and viral therapy for gliomas. Recent studies have highlighted transcriptional targeting as one of the possible solutions to overcome this limitation. In this context, melanoma associated antigens (MAAs) are usually over-expressed in brain tumors in comparison to normal brain tissue. For this reason, we in...
متن کاملAdenoviral vector systems for gene therapy
Adenoviral (Ad) vectors are widely used in gene therapies, recombinant viral vaccines, and basic science studies. The vectors can deliver therapeutic genes into cells to recover the lost function of some genes, to enhance the ability of host immune systems, or to increase the sensitivity of cancer cells to chemotherapeutic drugs. Several adenoviral vector systems have been developed: first-gene...
متن کاملAdenoviral vector-mediated gene transfer for human gene therapy.
Human gene therapy promises to change the practice of medicine by treating the causes of disease rather than the symptoms. Since the first clinical trial made its debut ten years ago, there are over 400 approved protocols in the United States alone, most of which have failed to show convincing data of clinical efficacy. This setback is largely due to the lack of efficient and adequate gene tran...
متن کاملConstruction of recombinant adenoviral vector carrying cyclinA2 gene.
Cell cycle related molecules in mammalian cochleae could provide a new avenue to restore hearing loss caused by a variety of genetic and environmental insults. CyclinA2 is one of the most important regulators of cell cycle, but its role in the mammalian cochlea is still unknown. So, it is necessary to construct an adenovirus vector carrying cyclinA2 gene for clarifying its function in the cochl...
متن کاملImmune parameters affecting adenoviral vector gene therapy in the brain.
Gene therapy utilizing replication deficient adenoviral vectors represents a potentially promising approach to the treatment of brain tumors. Limited duration of systemic transgene expression and inefficient transduction following repeat systemic vector administration secondary to an effective anti-vector immune response limits the potential application of first generation adenoviral vectors. W...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer Gene Therapy
سال: 2006
ISSN: 0929-1903,1476-5500
DOI: 10.1038/sj.cgt.7700962